A 2-part, Cross-over Trial of NOMAC-E2 to Assess Bioequivalence Between the Phase 3 Pivotal Clinical Batches and a Batch Prepared Using the Commercial Drug Manufacturing Process
Latest Information Update: 11 Feb 2022
At a glance
- Drugs Estradiol/nomegestrol (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme; Organon; Schering-Plough
Most Recent Events
- 06 May 2011 New trial record